The plasma levels of the incretin hormone glucagon-like peptide 1 (GLP-1), which has antihyperglycemic properties through the activation of GLP-1 receptor, can increase when receiving metformin, which can lead to insulin resistance [34]. The gene discussed is GLP1R; the disease is Insulin resistance.